HSE enter 'final stages' of talks for Cystic Fibrosis drug Orkambi
The HSE will today enter the 'final stages' of talks to agree the price of a major new drug for Cystic Fibrosis.
Senior management will spend the rest of the week in discussions with Vertex over the cost of the drug Orkambi.
Lunchtime News
Newsletter
Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.



